GFM COMBOLA
GFM COMBOLA Part A: Phase I/II Study of Luspatercept + EPO in Patients With Lower-Risk, Ring Sideroblast–Negative MDS After ESA Failure

Released: December 10, 2024

Expiration: December 09, 2025

Activity

Progress
1
Course Completed